Suppression of Experimental Autoimmune Uveoretinitis with a Combination of Cyclosporin and Alloprinol.

Accession number;99A0207596
Title;Suppression of Experimental Autoimmune Uveoretinitis with a Combination of Cyclosporin and Alloprinol.
Author; MATSUURA GAKUSHI (Tokyo Medical College) GOTO HIROSHI (Tokyo Medical College) KEZUKA TAKESHI (Tokyo Medical College) YAMAKAWA NAOYUKI (Tokyo Medical College) USUI MASAHIKO (Tokyo Medical College)
Journal Title;Journal of Japanese Ophthalmological Society
Journal Code:Z0666A
ISSN:0029-0203
VOL.103;NO.1;PAGE.26-33(1999)
Figure&Table&Reference;FIG.6, TBL.4, REF.26
Pub. Country;Japan
Language;Japanese
Abstract;Purpose: We assessed the suppressive effect of a combination of cyclosporin(an immunosuppressive agent) and allopurinol(a xanthine oxidase inhibitor and radical scavenger) on experimental autoimmune uveoretinitis(EAU) in Lewis rats, induced by interphotoreceptor retinoid-binding protein(IRBP). Methods: After the immunization of Lewis rats with 30.MU.g of IRBP. We administrated cyclosporin and/or allopurinol to the IRBP-immunized Lewis rats. We observed the incidence and the severity of EAU. Histological, immunological, and biochemical examinations were performal 13 days after the immunization. The suppressive effect of these drugs in vitro on the production of free radicals derived from polymorphonuclear leukocytes. Results: The incidence of EAU was suppressed by 50% at 13 days after immunization, and in terms of clinical and histological findings, inflammatory reaction was more inhibited by the combination of these drugs than by either cyclosporin or allopurinol alone. Lymphocyte proliferation assay against IRBP was significantly inhibited by the combination of drugs. No adverse systemic effects were identified. Cyclosporin and allopurinol inhibited radical production both separately and in combination. Conclusion: This suggests that suppression of EAU is based not only on inhibited cell-mediated immunity but also on inhibited production of free radicals derived from polymorphonuclear leukocytes. (author abst.)
FULLTEXT